Characteristics of Seltorexant-Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety

Molecules. 2023 Apr 19;28(8):3575. doi: 10.3390/molecules28083575.

Abstract

Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In this review, we present the role of the orexin system in the development of depressive illness and show the characteristics of seltorexant, a potential drug for the treatment of depression. This review describes the structure and synthesis of the compound as well as its pharmacodynamics and pharmacokinetics. Pre-clinical and clinical studies are also described, including side effects. There is evidence that the use of seltorexant is considered safe, with no clear or major clinically significant side effects, which makes it a promising candidate for the treatment of depression and anxiety disorders.

Keywords: anxiety; depression; orexin system; seltorexant.

Publication types

  • Review

MeSH terms

  • Anxiety / drug therapy
  • Anxiety Disorders / drug therapy
  • Depression* / drug therapy
  • Humans
  • Orexin Receptor Antagonists* / pharmacology
  • Orexin Receptor Antagonists* / therapeutic use
  • Orexins

Substances

  • Orexins
  • seltorexant
  • Orexin Receptor Antagonists

Grants and funding

The Statutory Funds of the Medical University of Lublin, Poland (DS 23/2023).